• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Nature >Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.
【24h】

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.

机译：肿瘤来源的p16等位基因编码在细胞周期抑制中有缺陷的蛋白质。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The cyclin-dependent kinase inhibitor p16 is a candidate tumour-suppressor protein that maps to a genomic locus strongly associated with familial melanoma and other tumour types. Screening of primary tumours and linkage analysis of familial melanoma pedigrees have identified many potential mutations in p16, but the functional significance of these sequence variants has remained unclear. We report here that p16 can act as a potent and specific inhibitor of progression through the G1 phase of the cell cycle, and we demonstrate that several tumour-derived alleles of p16 encode functionally compromised proteins. The ability of p16 to arrest cell-cycle progression generally correlates with inhibition of cyclin D1/Cdk4 kinase activity in vitro, with two exceptions among the alleles tested. In vivo, the presence of functional retinoblastoma protein appears to be necessary but may not be sufficient to confer full sensitivity to p16-mediated growth arrest. Our results provide support for the notion that p16 is an important cell-cycle regulator whose inactivation contributes to the outgrowth of human tumours.
机译：细胞周期蛋白依赖性激酶抑制剂p16是候选肿瘤抑制蛋白，可定位到与家族性黑色素瘤和其他肿瘤类型密切相关的基因组位点。原发性肿瘤的筛选和家族性黑色素瘤谱系的连锁分析已鉴定出p16有许多潜在的突变，但这些序列变异的功能意义仍不清楚。我们在这里报告说，p16可以作为通过细胞周期G1期进展的有力和特异性抑制剂，并且我们证明了p16的几个肿瘤衍生等位基因编码功能受损的蛋白质。 p16阻止细胞周期进程的能力通常与体外细胞周期蛋白D1 / Cdk4激酶活性的抑制有关，测试的等位基因中有两个例外。在体内，功能性成视网膜细胞瘤蛋白的存在似乎是必需的，但可能不足以赋予对p16介导的生长停滞的完全敏感性。我们的结果为p16是重要的细胞周期调节剂这一观念提供了支持，p16的失活有助于人类肿瘤的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号